The study by Qin et al. suggests that WWP2 regulates glycolysis and proliferation of liver cancer cells in an m6A-dependent manner, and is also associated with the resistance of liver cancer to doxorubicin therapy. This evidence concerns the gene WWP2 and liver cancer.